Brent L. Saunders - Director at BridgeBio Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
BBIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brent L. Saunders since 7/7/2023

Holdings reported by Brent L. Saunders for BridgeBio Pharma, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 17,600 $668 K $37.97 Dec 29, 2021 Direct
Stock Option (right to buy) 104,921 Jun 22, 2022 Direct Common Stock

Transactions reported by Brent L. Saunders for BridgeBio Pharma, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership